Champions Oncology (CSBR) Revenue (2010 - 2026)

Champions Oncology's Revenue history runs 17 years deep, the most recent figure standing at $16.6 million for Q1 2026.

• In Q1 2026, Revenue fell 2.82% year-over-year to $16.6 million; the TTM figure through Jan 2026 stood at $57.9 million (down 1.1% YoY), while the FY2025 annual figure was $56.9 million, up 13.54% from the prior year.
• Revenue was $16.6 million for Q1 2026 at Champions Oncology, up from $15.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $17.0 million in Q1 2025 to a low of $11.6 million in Q4 2023.
• Historically, Revenue has averaged $13.7 million across 5 years, with a median of $13.5 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Revenue dropped 18.96% in 2023, then jumped 41.77% in 2025.
• A 5-year view of Revenue shows it stood at $14.3 million in 2022, then decreased by 18.96% to $11.6 million in 2023, then grew by 16.56% to $13.5 million in 2024, then increased by 11.46% to $15.0 million in 2025, then grew by 10.14% to $16.6 million in 2026.
• The last three Revenue figures came in at $16.6 million (Q1 2026), $15.0 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.